Table 2.

Study criteria for NIBS study eligibility for children with CP.

Inclusion criteria

Exclusion criteria

Congenital unilateral cerebral palsy secondary to periventricular leukomalacia or perinatal stroke confirmed by most recent MRI or CT radiologic report with resultant congenital hemiparesis Receptive language function to follow two-step commands A determination by the investigators and institutions, as to the time since last seizure or age since seizure-free, with documentation of all current medications to include anti-epileptic medications Presence of a motor-evoked potential from at least the contralesional hemisphere (if not both hemispheres) for measurement of baseline cortical excitability and as a guide for site of stimulation Able to give informed assent along with the informed consent of a legal guardian Children who have surgeries, which may influence motor function (e.g., tendon transfers). Surgical history should be documented

Metabolic disorders Neoplasm Acquired traumatic brain injury Pregnancy Indwelling metal or incompatible medical devices Evidence of skin disease or skin abnormalities Spasticity injections such as Botulinum Toxin or Phenol Block within the previous 6 months so as not to potentially influence outcomes related to NIBS intervention

MRI, magnetic resonance imaging, CT, computerized tomography.